Edap TMS (Edap TMS) Gross-Profit-to-Asset % : 37.47% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Edap TMS Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Edap TMS's annualized Gross Profit for the quarter that ended in Dec. 2023 was $37.35 Mil. Edap TMS's average Total Assets over the quarter that ended in Dec. 2023 was $99.69 Mil. Therefore, Edap TMS's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 37.47%.

Edap TMS Gross-Profit-to-Asset % Historical Data

The historical data trend for Edap TMS's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS Gross-Profit-to-Asset % Chart

Edap TMS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

40.79

35.46

26.96

26.37

25.73

Edap TMS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															29.01	24.03	23.21	17.52	37.47

Competitive Comparison of Edap TMS's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Edap TMS's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Edap TMS's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Edap TMS's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Edap TMS's Gross-Profit-to-Asset % falls into.

Edap TMS Gross-Profit-to-Asset % Calculation

Edap TMS's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	26.621	/	( (107.122	+	99.834)	/ 2 )
	=	26.621	/	103.478
	=	25.73 %

Edap TMS's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	37.348	/	( (99.536	+	99.834)	/ 2 )
	=	37.348	/	99.685
	=	37.47 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Edap TMS Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Edap TMS's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Edap TMS (Edap TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

EDA:Germany

Address

Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120

Website

https://www.edap-tms.com

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.